Pharmacokinetics and safety of the novel oral renin inhibitor aliskiren in patients with type 2 diabetes.

被引：3
|
作者：
Vaidvanathan, S [1 ]
Zhao, C [1 ]
Yeh, C [1 ]
Dieterich, H [1 ]
机构：
[1] Novartis Pharma AG, Novartis Pharmaceut, E Hanover, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.042
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P12 / P12
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics, safety, and tolerability of the oral renin inhibitor aliskiren in patients with hepatic impairment
    Vaidyanathan, Sujato
    Warren, Vance
    Yeh, ChingMing
    Bizot, Marie-Noelle
    Dieterich, Hans Armin
    Dole, William R.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (02): : 192 - 200
  • [2] Pharmacokinetics, safety and tolerability of the novel oral direct renin inhibitor aliskiren in elderly subjects
    Vaidyanathan, Sujata
    Reynolds, Christine
    Yeh, Ching-Ming
    Bizot, Marie-Noelle
    Dieterich, Hans Armin
    Dole, William P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1072 - 1072
  • [3] Safety, tolerability and pharmacokinetics of the oral direct renin inhibitor aliskiren in patients with hepatic impairment
    Vaidyanathan, Sujata
    Warren, Vance
    Yeh, Ching-Ming
    Bizot, Marie-Noelle
    Dieterich, Hans Armin
    Dole, William P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1072 - 1072
  • [4] Pharmacokinetics, safety, and tolerability of the novel oral direct renin inhibitor aliskiren in elderly healthy subjects
    Vaidyanathan, Sujata
    Reynolds, Christine
    Yeh, Ching-Ming
    Bizot, Marie-Noelle
    Dieterich, Hans Armin
    Howard, Dan
    Dole, William P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (04): : 453 - 460
  • [5] Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor
    Buczko, Wlodzimierz
    Hermanowicz, Justyna M.
    PHARMACOLOGICAL REPORTS, 2008, 60 (05) : 623 - 631
  • [6] The combination of aliskiren, a direct renin inhibitor, and losartan in patients with type 2 diabetes and nephropathy
    Parving, H. -H.
    Persson, F.
    Lewis, J. B.
    Lewis, E. J.
    Hollenberg, N. K.
    DIABETOLOGIA, 2008, 51 : S24 - S25
  • [7] Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension
    Verdecchia, Paolo
    Calvo, Carlos
    Moeckel, Volker
    Keeling, Lucy
    Satlin, Andrew
    BLOOD PRESSURE, 2007, 16 (06) : 381 - 391
  • [8] Aliskiren - A novel oral renin inhibitor for the treatment of hypertension
    Kalus, James S.
    FORMULARY, 2006, 41 (12) : 631 - 638
  • [9] Antihypertensive efficacy and safety of the oral renin inhibitor aliskiren in patients with hypertension: a pooled analysis
    Weir, M.
    Bush, C.
    Zhang, J.
    Keefe, D.
    Satlin, A.
    EUROPEAN HEART JOURNAL, 2006, 27 : 299 - 299
  • [10] Aliskiren an oral direct renin inhibitor
    Hermanowicz, Justyna M.
    Buczko, Wlodzimierz
    KARDIOLOGIA POLSKA, 2008, 66 (10) : S358 - S361
12345